Skip to main content
Premium Trial:

Request an Annual Quote

Digilab Acquires BioVisioN to Develop Disease-Management Products

NEW YORK, Feb. 27 (GenomeWeb News) - Digilab announced today that it has acquired peptide-profiler BioVisioN.

 

"We plan to integrate proprietary Digilab tools into research processes and ultimately disease management systems," said Digilab President David Giddings in a statement.

 

Financial detailes were not released.

 

BioVisioN patented the Peptidomics technology and Differential Peptide Display software for peptide biomarker discovery. It is based in Hannover, Germany.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more